Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Expression of HER2/neu in premalignant lesions of oral cavity

Vansh Verma, Ashesh Kumar Jha, Karsing Patiri, Nikhil Arora
doi: https://doi.org/10.1101/2020.07.24.20161489
Vansh Verma
1Dr.Baba Saheb Ambedkar Medical College and Hospital, Rohini, New Delhi
Roles: Student
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashesh Kumar Jha
2Dept of Surgery, Dr.Baba Saheb Ambedkar Medical College and Hospital, Rohini, New Delhi
Roles: Associate professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: asheshjha04@gmail.com
Karsing Patiri
3Dept of Pathology, Dr.Baba Saheb Ambedkar Medical College and Hospital, Rohini, New Delhi
Roles: Assistant professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nikhil Arora
4At the time when work was carried out- Assistant professor, Dept of otolaryngology, Dr.Baba Saheb Ambedkar Medical College and Hospital, Rohini, New Delhi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Context Molecular alterations in premalignant lesions of oral cavity are not well known, many reports and have found increased HER2 expression to be correlated with poor prognosis in oral cancer. However, literature on expression of HER2 in premalignant lesions is limited and data is conflicting in nature. Overexpression of HER2 in premalignant lesions may denote its positive contribution in malignant transformation of these lesions.

Aims To evaluate the expression of HER2 in premalignant lesions of oral cavity.

Settings and Design In this prospective observational study of 2 months, patients attending OPD at Department of ENT and meeting the inclusion criteria were included.

Methods and Material 23 samples of Leukoplakia and 1 sample of oral lichen planus were stained by routine H&E to confirm clinical diagnosis and assess dysplasia if any, 5 samples of normal mucosa were used as control. Immunohistochemical staining for HER2 was done. ASCO/CAP 2018 guidelines were used for reporting the results.

Statistical analysis used Percentage of lesions expressing cytoplasmic or membranous expression was calculated.

Results 1 sample of Leukoplakia with severe dysplasia expressed focal membranous staining. 20% leukoplakia lesions expressed cytoplasmic staining. Staining was not observed in oral lichen planus and leucoplakia without dysplasia.

Conclusions Membranous expression in Severe dysplasia and higher expression in oral cancer is in concordance with the multistep theory of carcinogenesis. Larger studies are needed if HER2 is to be proposed as a marker for oral premalignant lesions. Significance of cytoplasmic staining in oral premalignant lesions needs to be elucidated.

Key Messages To the best of our knowledge, this is the first report of focal membranous expression of HER2 in leucoplakia in India. 20% leucoplakia with dysplasia expressed cytoplasmic staining. The significance of cytoplasmic staining needs to be further explored.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The study was funded by Indian council of medical research STS scheme vide reference number 2019-05752

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRB, Dr.Baba saheb ambedkar medical college and hospital approved the prohject on 15 Feb 2019. The proposal was also approved under ICMR STS scheme (ref number-2019-05752)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Email id- asusvv2017{at}gmail.com

  • Email id- drkarsingbsamch{at}gmail.com

  • Email id- for_nikhilarora{at}yahoo.com

  • Currently- Assistant Professor, Dept of otolaryngology, PGIMS Rohtak

Data Availability

The authors confirm that the data supporting the findings of this study are available within the article.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted July 24, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Expression of HER2/neu in premalignant lesions of oral cavity
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Expression of HER2/neu in premalignant lesions of oral cavity
Vansh Verma, Ashesh Kumar Jha, Karsing Patiri, Nikhil Arora
medRxiv 2020.07.24.20161489; doi: https://doi.org/10.1101/2020.07.24.20161489
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Expression of HER2/neu in premalignant lesions of oral cavity
Vansh Verma, Ashesh Kumar Jha, Karsing Patiri, Nikhil Arora
medRxiv 2020.07.24.20161489; doi: https://doi.org/10.1101/2020.07.24.20161489

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pathology
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (50)
  • Cardiovascular Medicine (451)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5258)
  • Forensic Medicine (3)
  • Gastroenterology (195)
  • Genetic and Genomic Medicine (757)
  • Geriatric Medicine (80)
  • Health Economics (213)
  • Health Informatics (698)
  • Health Policy (358)
  • Health Systems and Quality Improvement (223)
  • Hematology (99)
  • HIV/AIDS (163)
  • Infectious Diseases (except HIV/AIDS) (5867)
  • Intensive Care and Critical Care Medicine (361)
  • Medical Education (104)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (764)
  • Nursing (43)
  • Nutrition (130)
  • Obstetrics and Gynecology (142)
  • Occupational and Environmental Health (231)
  • Oncology (479)
  • Ophthalmology (152)
  • Orthopedics (38)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (862)
  • Public and Global Health (2011)
  • Radiology and Imaging (348)
  • Rehabilitation Medicine and Physical Therapy (158)
  • Respiratory Medicine (285)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (76)
  • Surgery (109)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)